<DOC>
	<DOCNO>NCT00388193</DOCNO>
	<brief_summary>The purpose clinical trial prove efficacy follow new regimen treatment : - Administration anti-CD20 ( Rituximab ) combine chemotherapy . - Combined treatment high dos methotrexate high dos cytarabine conventional cytostatics ( block C ) - Prophylactic administration G-CSF chemotherapy cycle - local irradiation 6 cycle CNS affect residual tumour</brief_summary>
	<brief_title>Rituximab Combined With Chemotherapy Burkitt ` Lymphoma</brief_title>
	<detailed_description>Clinical Trial pharmaceutical speciality new condition use .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Burkitt Lymphoma</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Patients diagnosed mature LLAB cell ( LLAL3 ) Patients diagnose Burkitt´s Burkitt´s Like Lymphoma Patients 15 year old Written Informed Consent sign Serious complication related LAL3/LB Secondary illness : Serious complication , uncontrollable , example , sepsis , pneumonia hypoxia , shock , haemorrhage diagnosis . Renal failure unconditional Lymphoma/Leukemia Heart failure serious liver . Pulmonary obstructive disease serious restrictive allow treat patient intensive chemotherapy . Secondary Lymphoma chemotherapy previous radiotherapy second malignant tumour . Known hypersensitivity foreign protein . Previous treatment cytostatics LLAB Burkitt´s Lymphoma ( exception : administration short time glucocorticoid ≤ 7 day , one administration vincristine cyclophosphamide , one cycle CHOP , urgent administration another cytostatics ) . With another malignant tumour last 5 year . Women fertile age must give positive pregnancy test nursing mother . Mental disability emotional psychiatric significant disorder patient ca n't understand cooperate treatment . Patients enrol another clinical research study .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>ALL ( L3 )</keyword>
	<keyword>BURKITT 's LYMPHOMA</keyword>
	<keyword>RITUXIMAB</keyword>
</DOC>